Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Xamiol, calcipotriene/betamethasone dipropionate (Taclonex topical suspension)
Also known as: Taclonex Scalp (Taclonex Scalp gel) (LEO 80185)
print preview
bookmark
share with colleague
General Information
Company
Leo Pharma A/S
Description
Topical suspension containing 0.005% calcipotriene plus 0.064% betamethasone dipropionate
Molecular Target
Glucocorticoid receptor (GCCR)
Mechanism of Action
Glucocorticoid receptor agonist
Latest Stage of Development
Marketed
Indication
Psoriasis
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy